Rifampin's Effect on Tigecycline Levels
Rifampin significantly lowers tigecycline blood concentrations by inducing CYP3A4 enzymes, which accelerate tigecycline metabolism. This interaction reduces tigecycline's AUC by about 50% when co-administered, potentially compromising efficacy against infections like complicated skin/skin structure infections or intra-abdominal infections.[1][2]
Adjusted Dosing Recommendations
Standard tigecycline dosing is 100 mg IV loading dose, then 50 mg IV every 12 hours. With rifampin, increase to 100 mg IV every 12 hours (doubling the maintenance dose) to offset the interaction. Monitor clinically and consider therapeutic drug monitoring if available, as tigecycline levels vary widely.[1][3]
Why This Interaction Occurs
Rifampin, a potent CYP3A4 inducer, boosts tigecycline clearance via liver metabolism. Tigecycline itself weakly inhibits CYP3A4, but induction dominates, leading to subtherapeutic levels within days of combined use. Steady-state effects peak after 3-5 days of rifampin.[2][4]
Clinical Risks and Monitoring
Underdosing risks treatment failure, especially for multidrug-resistant pathogens where tigecycline is reserved. No increased toxicity reported with dose adjustment, but watch for tigecycline's nausea/vomiting or rifampin's hepatotoxicity. Avoid if alternatives exist; use only for confirmed necessity like tuberculosis/mycobacterial co-infections.[1][3]
Alternatives When Interaction Is a Concern
Switch to non-CYP3A4-dependent antibiotics like vancomycin, linezolid, or colistin for gram-positives/negatives. Time rifampin dosing 12 hours apart from tigecycline if adjustment isn't feasible, though this offers limited benefit.[2][4]
Sources
[1]: Tigecycline Prescribing Information (Pfizer)
[2]: FDA Drug Interactions Table
[3]: Lexicomp: Tigecycline-Rifampin Interaction
[4]: Clinical Pharmacology Study (PubMed: 19439420)